المؤلفون: Lees KR; From the School of Medicine, Dentistry, and Nursing, University of Glasgow, Glasgow, United Kingdom.

المصدر: The New England journal of medicine [N Engl J Med] 2021 Sep 09; Vol. 385 (11), pp. 1043-1044.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Mobile Health Units* , Stroke*/therapy, Humans

المؤلفون: Hacke W; Department of Neurology, Universität Heidelberg, Heidelberg, Germany. werner.hacke@med.uni-heidelberg.de, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D

مؤلفون مشاركون: ECASS Investigators

المصدر: The New England journal of medicine [N Engl J Med] 2008 Sep 25; Vol. 359 (13), pp. 1317-29.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Fibrinolytic Agents/*administration & dosage , Stroke/*drug therapy , Tissue Plasminogen Activator/*administration & dosage, Acute Disease ; Adult ; Aged ; Brain Ischemia/drug therapy ; Double-Blind Method ; Drug Administration Schedule ; Female ; Fibrinolytic Agents/adverse effects ; Humans ; Infusions, Intravenous ; Intracranial Hemorrhages/chemically induced ; Logistic Models ; Male ; Middle Aged ; Odds Ratio ; Stroke/complications ; Stroke/mortality ; Time Factors ; Tissue Plasminogen Activator/adverse effects ; Treatment Outcome

المؤلفون: Shuaib A; Division of Neurology, University of Alberta, Edmonton, Canada., Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U

مؤلفون مشاركون: SAINT II Trial Investigators

المصدر: The New England journal of medicine [N Engl J Med] 2007 Aug 09; Vol. 357 (6), pp. 562-71.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Benzenesulfonates/*therapeutic use , Brain Ischemia/*drug therapy , Cardiovascular Agents/*therapeutic use , Stroke/*drug therapy, Acute Disease ; Aged ; Benzenesulfonates/adverse effects ; Cardiovascular Agents/adverse effects ; Double-Blind Method ; Female ; Humans ; Infusions, Intravenous ; Male ; Odds Ratio ; Stroke/mortality ; Time Factors ; Treatment Failure

المؤلفون: Lees KR; Acute Stroke Unit and Cerebrovascular Clinic, University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow, United Kingdom. k.r.lees@clinmed.gla.ac.uk, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hårdemark HG, Wasiewski WW

مؤلفون مشاركون: Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators

المصدر: The New England journal of medicine [N Engl J Med] 2006 Feb 09; Vol. 354 (6), pp. 588-600.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Brain Ischemia/*drug therapy , Neuroprotective Agents/*therapeutic use , Nitrogen Oxides/*therapeutic use , Stroke/*drug therapy, Acute Disease ; Benzenesulfonates ; Brain Ischemia/complications ; Brain Ischemia/mortality ; Cross-Over Studies ; Disability Evaluation ; Double-Blind Method ; Drug Therapy, Combination ; Fibrinolytic Agents/therapeutic use ; Hemorrhage/prevention & control ; Humans ; Infusions, Intravenous ; Nervous System Diseases/diagnosis ; Nervous System Diseases/etiology ; Nervous System Diseases/prevention & control ; Neuroprotective Agents/adverse effects ; Nitrogen Oxides/adverse effects ; Severity of Illness Index ; Stroke/complications ; Stroke/mortality ; Time Factors ; Tissue Plasminogen Activator/therapeutic use ; Treatment Outcome